- 5-Fluoroisatin
-
- $0.00 / 1KG
-
2022-10-09
- CAS:443-69-6
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1Ton
- 5-Fluoroisatin
-
- $1.00 / 1KG
-
2019-07-06
- CAS:443-69-6
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: Customized
|
| 5-Fluoroisatin Basic information |
| 5-Fluoroisatin Chemical Properties |
Melting point | 224-227 °C (lit.) | density | 1.477±0.06 g/cm3(Predicted) | storage temp. | Sealed in dry,Room Temperature | solubility | Chloroform, DMSO, Methanol | pka | 8.51±0.20(Predicted) | form | Powder | color | Red | BRN | 131241 | InChIKey | GKODDAXOSGGARJ-UHFFFAOYSA-N | CAS DataBase Reference | 443-69-6(CAS DataBase Reference) |
Hazard Codes | Xi | Risk Statements | 36/37/38 | Safety Statements | 26-37/39-36 | WGK Germany | 3 | HazardClass | IRRITANT | HS Code | 29337900 |
| 5-Fluoroisatin Usage And Synthesis |
Chemical Properties | red Crystalline Powder | Uses | Reactant for preparation of:
- Spiro[indole-thiazolidinones] as biologically relevan synthesis scaffolds
- Potential antimycobacterial agents
- Inhibitors of c-Met kinase
- Inhibitors of TAK1 kinase
- Herpes simplex virus inhibitors
- IKKβ inhibitors
- Inhibitors of vitiligo disease
- Potential drug candidates with anti-HIV activity and anti-tubercular activity
| Uses | It showed antibacterial and antifungal activities. | Definition | ChEBI: 5-Fluoroisatin is a member of indoles. It has a role as an anticoronaviral agent. | General Description | 5-Fluoroisatin has been reported as the precursor of the Sunitinib (Sutent) drug. 5-Fluoroisatin has been approved by the Food and Drugs Administration (FDA) in 2006 for the treatment of renal cell carcinoma (RCC) and gastrointestinal stromal tumor (GIST). |
| 5-Fluoroisatin Preparation Products And Raw materials |
|